Archaeologist Greer Jarrett at Lund University in Sweden has been sailing in the footsteps of Vikings for three years. He can now show that the ...

In one of the most heart-stopping moments in carrier aviation, an EA-6B Prowler came dangerously close to colliding with a ...

Swedish archaeologists uncovered a rare 1,100-year-old Viking coffin grave containing weapons near Linköping, describing ...

The Minnesota Vikings enter the JJ McCarthy era with needs across their defense ahead of the 2025 NFL draft. Minnesota has used draft capital in recent years to fortify its offensive line and add ...

After agreeing to terms with 19 undrafted free agents over the weekend, the Vikings have added another. Minnesota announced on Wednesday that the club has agreed to terms with UDFA receiver Myles ...

Both Pfizer and Viking aim to enter the high-growth weight loss drug market. Analysts forecast this market could be worth as much as $130 billion just a few years from now. Big pharmaceutical ...

After letting Sam Darnold walk — despite leading them to a 14-3 season and throwing for 4,319 yards and 35 touchdowns — the Minnesota Vikings are all in on quarterback J.J. McCarthy.

The Minnesota Vikings are rewarding one of their best defensive playmakers, as the team agreed to a one-year, $23 million extension with outside linebacker Andrew Van Ginkel that includes $22.4 ...

In the second time in as many years, the Minnesota Vikings have a new starting quarterback. Former No. 10 overall pick J.J. McCarthy will take over for Sam Darnold in 2025, and there will be high ...

The hard-charging linebacker with free-flowing locks is staying in Minnesota beyond 2025. The Vikings are signing Pro Bowl linebacker Andrew Van Ginkel to a one-year, $23 million extension ...

A second analyst voices positive thoughts on Viking's new GLP-1 weight loss drug. Phase 3 clinical trial data on VK2735 arrives later this year, and phase 2 data on a GLP-1 pill could come out as ...

Shares of Viking Therapeutics (NASDAQ: VKTX) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall Street analysts. Seedhouse doesn't beat around the bush: "Our thesis is ...